Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

HealthLynked discusses year end financials and MedOfficeDirect prospects in development

HealthLynked discusses year end financials and MedOfficeDirect prospects in development

HealthLynked (OTCQB:HLYK) Chairman & CEO Dr. Michael Dent and Chief Financial Officer George O'Leary join Natalie Stoberman from the Proactive studios to share highlights from the company's fourth quarter and full year 2022 financial results.

HealthLynked has reported revenue of $5.86 million, a 10% decrease compared to $6.50 million in 2021. Dent says the decline is primarily attributed to decreases in patient service revenue at the Naples Women’s Center and Bridging the Gap facilities, as well as lower product revenue from MedOfficeDirect. However, the company has reported that the decrease was partially offset by revenue increases at its Naples Center for Functional Medicine facility and revenue from the newly-acquired Aesthetics Enhancements Unlimited practice.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK